Table 1.

Summary of patient demographics

Curcumin dose group
2 g (n = 22)4 g (n = 19)
Age, y (mean ± SD)57 ± 554 ± 7
Range, y51–7042–69
Personal/family history
 Adenoma1/1 (9%)1/2(15.8%)
 Colon Cancer0/2 (9%)0/0 (0%)
Gender
 Female13 (59%)11 (58%)
 Male9 (41%)8 (42%)
Race/ethnicity,%
 Caucasian3 (13.6%)8 (42.1%)
 African American18 (81.8%)9(47.4%)a
 Latino American1 (4.6%)1(5.3%)*
 Amerindian0 (0%)1(5.3%)
 Asian0 (0%)1(5.3%)
Tobacco pack-years (mean)21.7522.8
 1–15 pack-years10 (45%)5(26%)
 16–29 pack-years5 (23%)8(42%)
 ≥ 30 pack-years7 (32%)6(32%)
ACF number pretreatment
(mean ± SEM)15.0 ± 4.817.8 ± 2.0
  • aOne participant self-identified as both Latino- and African American.